Background: Mutations in the human telomerase reverse transcriptase (hTERT) gene
promoter have been reported in hepatocellular carcinoma (HCC); however, analyses of …

Telomerase reverse transcriptase (TERT) mutation is the most frequent genetic alteration in
hepatocellular carcinoma (HCC). Our aims were to investigate whether TERT mutations can …

AIM: To determine the mutation status of human telomerase reverse transcriptase gene
(TERT) promoter region in hepatocellular carcinoma (HCC) from different geographical …

Simple Summary Activating mutations in the promoter region of TERT (TERTp) gene are
frequently observed in low-and high-grade dysplastic nodules and defined as early events …

Background andAim Human telomerase reverse transcriptase (TERT) promoter mutations
were the most prevalent mutations in patients with hepatocellular carcinoma (HCC). We tried …

Abstract Background and Aim: Telomerase activation is essential for the immortality of
cancer cells. The expression of telomerase reverse transcriptase (hTERT), the catalytic …

Promoter mutations in telomerase reverse transcriptase (TERT) and telomere length have
been studied in various tumors. In the present study, the frequency and clinical …

Introduction Mutation in the core promoter of the telomerase reverse transcriptase (TERT)
gene was determined to be a frequent event in malignant melanoma and other cancers …

Reactivation of telomerase is a critical step in the development of hepatocellular carcinoma
(HCC). Here we identified the frequency of mutations in telomerase reverse transcriptase …

Telomerase reverse transcriptase (TERT) promoter mutation is the most frequent genetic
alteration in hepatocellular carcinoma (HCC). However, there is currently no suitable highly …